Chandagirikoppal V. Kavitha and Gagan Deep contributed equally to this work and share first authorship.
Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells
Article first published online: 31 OCT 2012
© 2013 Wiley Periodicals, Inc.
Volume 53, Issue 3, pages 169–180, March 2014
How to Cite
Kavitha, C. V., Deep, G., Gangar, S. C., Jain, A. K., Agarwal, C. and Agarwal, R. (2014), Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells. Mol. Carcinog., 53: 169–180. doi: 10.1002/mc.21959
- Issue published online: 21 FEB 2014
- Article first published online: 31 OCT 2012
- Manuscript Accepted: 23 AUG 2012
- Manuscript Revised: 20 AUG 2012
- Manuscript Received: 29 MAY 2012
Additional supporting information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.